An assessment of the updated results from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial: An evidence-based medicine approach

被引：0

作者：

Edwards, SJ ^{[1
]}

机构：

[1] AstraZeneca UK Ltd, Luton, Beds, England

来源：

VALUE IN HEALTH | 2003年 / 6卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)61864-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：731 / 731

页数：1

共 50 条

[21] The ATAC ('Arimidex', Tamoxifen, alone or in combination) early breast cancer trial in postmenopausal patients: endometrial sub-protocol results
Duffy, S
Jackson, T
INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 138
[22] The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in postmenopausal (PM) women.
Baum, M
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 210 - 210
[23] Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial
Fallowfield, L
Cella, D
Cuzick, L
Francis, S
Locker, G
Howell, A
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4261 - 4271
[24] Effect of anastrozole on bone mineral density: 5-year results of the 'Arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
不详
CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S25 - S25
[25] Efficacy data from the ATAC ("arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment
不详
BREAST, 2005, 14 : S51 - S51
[26] Effect of anastrozole on bone mineral density: 2-year results of the 'arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) trial
Howell, A
BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S27 - S27
[27] Analysis of fracture risk factors from the 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) trial: 5-year data.
Howell, A.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 18S - 18S
[28] Using anastrozole as initial adjuvant treatment prevents early recurrences and reduces adverse events: Updated data from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
Houghton, J
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 24S - 24S
[29] Impact of age on the gynecologic adverse event (AE) profile of anastrozole (A) or tamoxifen (T) in the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial.
Distler, W
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 69S - 69S
[30] Effect of anastrozole on bone density and bone turnover: Results of the 'Arimidex' (anastrozole), tamoxifen, alone or in combination (ATAC) study.
Eastell, R
Hannon, RA
Cuzick, J
Clack, G
Adams, JE
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S165 - S165

← 1 2 3 4 5 →